Verified Patient
Recent
Yes — you can start the exact Zepbound medicine in Thailand. Eli Lilly sells this tirzepatide here as Mounjaro: same molecule, same maker, doctor-prescribed and authentic. Cold-chain from our Pattaya clinic or couriered to your hotel — message us for eligibility and today’s pen price.
Treatments supervised by Dr. Kenika Norrachetdecha
Medical Director · Thai License #72509
Personal consultation included with every program
That's −17.8 kg — you'd weigh .
Based on the 20.9% trial-mean. Individual outcomes vary.
Licensed medical facility · Real photos · Dr. Kenika
Counterfeit GLP-1 medicines are a real problem in unregulated channels. The authentic Mounjaro we dispense ships through pharmacy distribution, every pen traceable back to Eli Lilly.
Every pen carries the Eli Lilly logo, the brand name "Zepbound", lot number, NDC code, and expiration date — identical to pens dispensed in US pharmacies. We do not unbox or relabel.
Refrigerated from Eli Lilly warehouse to our pharmacy to your hands. Temperature monitored on every shipment. No grey-market re-export.
Your first dose is administered by Dr. Kenika or our nurse — in clinic in Pattaya, at your hotel in Bangkok, or via guided video for remote patients. You inspect the pen markings before injection.
Every patient receives the lot number and expiration date of their pen on the prescription record. You can cross-check against Eli Lilly's batch documentation on request.
Eli Lilly markets tirzepatide under two names. In the United States the obesity brand is Zepbound; across most of the world — including Thailand — the same molecule is sold as Mounjaro. Different label, identical active ingredient, same manufacturer. The dosing ladder is the same (2.5 to 15 mg), and the SURMOUNT-1 results quoted for Zepbound are the data for this exact tirzepatide.
Worth knowing: in Thailand the legitimate Eli Lilly tirzepatide is branded Mounjaro, not Zepbound — so that is the authentic product we prescribe and dispense.
Eli Lilly uses the Zepbound brand almost exclusively in the United States. Everywhere else, the identical tirzepatide reaches patients as Mounjaro. If you are travelling or relocating, here is what the same molecule is called where you are going:
| Region | Brand for this tirzepatide |
|---|---|
| United States | Zepbound (obesity) / Mounjaro (diabetes) |
| Thailand | Mounjaro — what we dispense |
| UK, EU, Australia, Singapore | Mounjaro |
Continuity for expats: if you started Zepbound in the US, you do not interrupt treatment in Thailand. Dr. Kenika reviews your current milligram and continues you on Mounjaro at the same strength — same molecule, same titration ladder, no washout. You also avoid carrying pens through customs: we dispense locally and courier refills for the length of your stay.
Zepbound is FDA-approved for chronic weight management in adults with obesity (BMI ≥30) or overweight (BMI ≥27) plus at least one weight-related comorbidity (such as hypertension, dyslipidemia, type 2 diabetes, obstructive sleep apnea, or cardiovascular disease)[1]. The molecule — Tirzepatide — is the same one marketed under the Mounjaro brand for Type 2 diabetes.
Zepbound activates two gut-hormone receptors simultaneously. GLP-1 slows gastric emptying and suppresses appetite; GIP enhances fat metabolism. The dual mechanism produces substantially stronger weight reduction than GLP-1-only medicines.
Read more on our Tirzepatide Thailand page.
Zepbound: Obesity / chronic weight management (FDA-approved November 2023)[3]. Mounjaro: Type 2 diabetes (FDA-approved May 2022)[5]. Both contain Tirzepatide manufactured by Eli Lilly. Same pen format, same dose strengths, same titration schedule.
See the diabetes brand on our Mounjaro Thailand page.
Doctor-led · Authentic Eli Lilly · Cold-Chain
↑ Take-home pens available from 13,990 ฿/month
Zepbound (tirzepatide) is FDA-approved for chronic weight management. Pharmacologically identical to Mounjaro — same Eli Lilly molecule, indication-specific labeling.
Per-shot pricing at higher doses confirmed during your consultation. Final program pricing depends on your dose plan and treatment duration. Thai pharmacy advertising regulations preclude binding online prices — your exact figure is shared in private medical review.
Trajectory based on the SURMOUNT-1 clinical-trial mean. Your individualized program is confirmed in consultation — this is an evidence-based estimate, not a guarantee.
Your trajectory · based on SURMOUNT-1 mean (Zepbound)
Estimator uses peer-reviewed clinical-trial mean data. Individual outcomes vary based on adherence, baseline BMI, comorbidities, and lifestyle factors. Final program plan determined in private medical consultation.[ref]
Tirzepatide follows the Eli Lilly prescribing-information titration. Incremental dose increases minimize GI side effects and allow your body to adapt to the appetite-suppressing effect.
Source: Eli Lilly Zepbound full prescribing information. Schedule may be adjusted individually by Dr. Kenika.
15-minute WhatsApp with our clinic team. Share your goals, history, and questions. No commitment.
Dr. Kenika reviews your history. Labs ordered if needed. Treatment plan decided based on your specific clinical picture.
First dose at clinic or cold-chain delivery to your address. Titration plan + side-effect support from day one.
Weekly check-ins during titration. Dose adjusted to your response. Sustainable maintenance plan together.
Every Zepbound patient is personally supervised by Dr. Kenika — medical history review, HbA1c monitoring where relevant, dose decisions, titration adjustments. No intake-form-only approval.
Authentic Zepbound from Eli Lilly via cold-chain pharmacy distribution. Batch numbers and expiry dates intact. No compounded substitutes, no grey-market sourcing.
In-clinic in Pattaya, concierge nurse to your hotel in Bangkok, or online consultation with cold-chain delivery in Phuket and beyond.
Real reviews from real patients on Google Business Profile. Currently 5.0 ★ verified reviews — and growing.
Request a consultation. Our clinic team responds within minutes on WhatsApp and walks you through eligibility, dose plan, sourcing verification, and the access mode that fits your location.
Request consultation
FDA prescribing information, peer-reviewed clinical trials, and manufacturer documentation.
Additional clinical questions are discussed during your private consultation with Dr. Kenika.
Each GLP-1 protocol has a different mechanism, trial profile, and outcome ceiling. Compare or explore by location.
Dual GIP/GLP-1 receptor agonist. Highest trial-mean of any approved GLP-1 medicine.
See program →
Most-prescribed GLP-1 in clinical practice. Excellent track record for goals up to 15%.
See program →
Investigational GLP-1/GIP/Glucagon triple agonist. Highest documented mean reduction in incretin trials.
See program →
In-person consultation, baseline labs, same-week start. Walk-in friendly.
See program →